Garzozi HJ, Shehadeh-Masha'our R, Somri M, Kagemann L, Harris A. The Effects of Droperidol in Perforating Keratoplasty.
Ophthalmologica 2006;
220:242-5. [PMID:
16785755 DOI:
10.1159/000093078]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2005] [Accepted: 11/04/2005] [Indexed: 11/19/2022]
Abstract
PURPOSE
To evaluate the intraoperative and postoperative effects of droperidol administered with general anesthesia during perforating keratoplasty.
METHODS
A prospective, randomized, double-masked clinical trial. Twenty-seven patients undergoing penetrating keratoplasty under general anesthesia were included. Patients were assigned randomly to two groups. Fifteen subjects received droperidol during induction of general anesthesia. Twelve control patients received general anesthesia without droperidol.
RESULTS
Droperidol significantly reduced fellow eye intraocular pressure (p < 0.0001). Intraoperative anterior chamber depth was significantly deeper with droperidol (p = 0.0002). Iris bulging was observed in 25% of the control group and 0% with droperidol. There was significantly less postoperative nausea in the droperidol group (p = 0.038). There was less postoperative vomiting in the droperidol group, although the difference was not significant (p = 0.07). Postoperative wound gaping was observed in 2 patients; both of them did not receive droperidol.
CONCLUSIONS
Droperidol effectively reduces intraoperative and postoperative complications in keratoplasty surgery.
Collapse